Genetic Confirmation of Atovaquone-Proguanil-Resistant Plasmodium falciparum Malaria Acquired by a Nonimmune Traveler to East Africa
Open Access
- 1 August 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (3) , 450-451
- https://doi.org/10.1086/375599
Abstract
We report a case of atovaquone-proguanil–resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to Kenya. Recurrent parasitemia occuKeywords
This publication has 9 references indexed in Scilit:
- A Molecular Surveillance System for Global Patterns of Drug Resistance in Imported MalariaEmerging Infectious Diseases, 2003
- Illness after International TravelNew England Journal of Medicine, 2002
- Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, NigeriaMalaria Journal, 2002
- Malaria Chemoprophylaxis in the Age of Drug Resistance. I. Currently Recommended Drug RegimensClinical Infectious Diseases, 2001
- Prophylactic effect of Malarone against malaria: all good news?The Lancet, 2000
- Mutations in Plasmodium falciparum Cytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding SiteAntimicrobial Agents and Chemotherapy, 2000
- Determination of Failure of Treatment of Plasmodium falciparum Infection by Using Polymerase Chain Reaction Single‐Strand Conformational Polymorphism FingerprintingClinical Infectious Diseases, 1999
- Atovaquone, a Broad Spectrum Antiparasitic Drug, Collapses Mitochondrial Membrane Potential in a Malarial ParasiteJournal of Biological Chemistry, 1997
- Clinical Studies of Atovaquone, Alone or in Combination with other Antimalarial Drugs, for Treatment of Acute Uncomplicated Malaria in ThailandThe American Journal of Tropical Medicine and Hygiene, 1996